Cancer diagnosis delays could cost thousands of lives
Posted: 2nd October 2020
Categories: Industry news
Delays to cancer diagnosis caused by COVID-19 could be responsible for thousands of avoidable deaths in the UK, a new report study published in The Lancet has found. In a ground-breaking new population-based modelling study, a London-based research team has attempted to calculate the impact of the coronavirus pandemic on cancer diagnosis and treatment outcomes. […]
Scientists identify new biomarker for cancer diagnosis
Posted: 2nd October 2020
Categories: Industry news
Scientists have identified tiny packages of materials released by tumours, called EVPs (extracellular vesicles and particles) that could be a potential biomarker for detecting several types of cancer at an early stage. In a recent study, published in the prestigious Cell journal, a US-based team have identified an exciting new biomarker that could lead to […]
Nutrition as a ‘precision medicine’ in cancer treatment
Posted: 10th September 2020
Categories: Industry news
We know that a healthy diet and good nutrition might contribute in reduction of risk of certain cancers. Diets that are high in plant foods – such as fruit, vegetables, wholegrains and beans – may protect against certain cancers. For example, diets with a high proportion of these fibre-rich foods can protect against bowel cancer. […]
Liquid biopsy blood tests could be used to diagnose brain tumours
Posted: 26th August 2020
Categories: Industry news
Results of a promising trial in people with brain tumours suggests that a specific blood test could be used for more accurate diagnosis, without the need for invasive procedures. The blood test based on circulating-tumour DNA (ctDNA) has been found to accurately classify different types of brain tumours and could allow for better treatment planning […]
Simple blood tests can be used to look for resistance to chemotherapy
Posted: 15th July 2020
Categories: Industry news
When it comes to treating cancer, there’s good news and bad news. Part of the good news is that there are many effective medicines, known as chemotherapies, that can treat cancer and improve survival. The not so good news is that some cancers that initially respond to chemotherapy can become resistant to treatment. This means […]
Circulating tumour cells may predict breast cancer outcomes
Posted: 30th June 2020
Categories: Industry news
Breast cancer is the second most common cancer worldwide and there were over 2 million new cases in 2018, according to the World Cancer Research Fund. So there is great research interest in understanding more about what determines how likely people with breast cancer are to survive, and to respond to treatment. Researchers at Cleveland […]
Liquid biopsies shed light on cancer drug resistance
Posted: 18th June 2020
Categories: Industry news
It is not uncommon for people with cancer to have treatment with a drug that is initially effective at shrinking their tumour, only for it to grow back as the cancer cells in the tumour evolve and become resistant to the drugs. It is estimated that drug resistance and the resulting ineffectiveness of treatments are […]
In the first study of its kind, researchers have used a simple blood test to safely detect multiple cancers in nearly 10,000 women with undiagnosed cancer. In some cases, women who took the blood test were able to have treatment to potentially cure the cancer. The researchers at the Johns Hopkins Kimmel Cancer Center in […]
RGCC Investigates Potential Treatments and Tests for COVID-19
Posted: 7th May 2020
Categories: Industry news, RGCC news
As the world tries to cope with the rise in cases of covid-19 during the coronavirus pandemic, drug companies are racing to develop treatments that could reduce the number of deaths from the illness. This includes the specialist medical genetic testing company RGCC, which has turned its expertise and technology in the diagnosis and treatment […]
Researchers have developed a blood test that can detect more than 50 common and deadly cancers, often before symptoms appear. The test could be especially useful in 12 cancers it was most accurate at detecting. These included pancreatic cancer, which is often only diagnosed at a very late stage and has poor outcomes and survival. […]
New test could spot early signs of prostate cancer
Posted: 3rd April 2020
Categories: Industry news
Researchers have used genetic testing to detect the very early changes that occur in the tumours of men with prostate cancer. Researchers at the University College London (UCL) Cancer Institute say the new type of blood test will help them understand the genetic characteristics of the tumours that cause prostate cancer, which is the second […]
Study shows genetic changes can occur years before diagnosis
Posted: 23rd March 2020
Categories: Industry news
A study suggests the genetic changes that cause cancers can happen years or even decades before the disease is diagnosed. A large analysis by an international team of researchers revealed that many DNA mutations – the changes in our genome that can trigger a tumour to develop – can occur long before someone is diagnosed […]